Imagining the Future of Human Longevity feat. Mariya Filipova and Aubrey de Grey

Episode 6: Imagining the Future of Human Longevity feat. Mariya Filipova and Aubrey de Grey 

In this week’s episode, Dr. Emily Church, Executive Director of Equity & Education at XPRIZE, drops in on a conversation between two leaders in the healthcare and human longevity space -- author and biomedical gerontologist Aubrey de Grey and Mariya Filipova, VP of Innovation at Anthem --  as they share their thoughts on the keys to improving quality of life for everyone, everywhere.

Mariya Filipova helps organizations accelerate their digital transformation by deploying the full potential of exponential technologies and business models to optimize their talent, product development and revenue generation capabilities. In Healthcare, Mariya curates high performing ecosystems to identify, pilot and scale initiatives that transform care management and delivery. She is a trusted advisor to healthcare veterans and new entrants from start-ups to established industry leaders in e-commerce, retail and tech. 

In her current role, Ms. Filipova leads Innovation for Anthem, one of the largest health benefits platforms serving over 70M people in the US. Mariya previously led Deloitte’s global Future of Work Office, a portfolio of investments that use exponential technologies (e.g. blockchain, artificial intelligence) to redefine the way we do and monetize work. Ms. Filipova’s past experience as entrepreneur and wall street analyst at Barclays Capital has shaped her perspective on transformation in closely regulated industries in Europe and the US.

Ms. Filipova holds an MBA from Harvard Business School and a BA in Economics, summa cum laude, from Mount Holyoke College. She remains active in her alumni community where she serves on the Board of Governors for the Harvard Business School of Association of Boston. She is currently based in Boston, MA.

Dr. Aubrey de Grey is a biomedical gerontologist based in Cambridge, UK and Mountain View, California, USA, and is the Chief Science Officer of SENS Foundation, a California-based 501(c)(3) charity dedicated to combating the aging process. He is also Editor-in-Chief of Rejuvenation Research, the world highest-impact peer-reviewed journal focused on intervention in aging. He received his BA and Ph.D. from the University of Cambridge in 1985 and 2000 respectively. His original field was computer science, and he did research in the private sector for six years in the area of software verification before switching to biogerontology in the mid-1990s. His research interests encompass the characterization of all the accumulating and eventually pathogenic molecular and cellular side-effects of metabolism that constitute mammalian aging and the design of interventions to repair and/or obviate that damage. He has developed a possibly comprehensive plan for such repair, termed Strategies for Engineered Negligible Senescence (SENS), which breaks aging down into seven major classes of damage and identifies detailed approaches to addressing each one. A key aspect of SENS is that it can potentially extend healthy lifespan without limit, even though these repair processes will probably never be perfect, as the repair only needs to approach perfection rapidly enough to keep the overall level of damage below pathogenic levels. Dr. de Grey has termed this required rate of improvement of repair therapies longevity escape velocity.

Dr. de Grey is a Fellow of both the Gerontological Society of America and the American Aging Association, and sits on the editorial and scientific advisory boards of numerous journals and organizations.

Links: 

https://www.anthem.com/

https://www.sens.org/

https://xprize.org/blog

See acast.com/privacy for privacy and opt-out information.